Know Cancer

or
forgot password
  • cancer clinical trials in madison, WI

  • Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Nicholas Hospital
    Madison, Wisconsin 53715
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer
    MC-5A for Chemotherapy Induced Peripheral Neuropathy
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Neuropathy, Paraneoplastic
    Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Breast Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Dean Hematology and Oncology Clinic
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Saint Nicholas Hospital
    Madison, Wisconsin 53715
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
    University of Wisconsin Cancer Center

    Trial Locations
    University of Wisconsin Cancer Center
    UW Health Oncology- 1 S Park
    Non-Hodgkins Lymphoma
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Head and Neck Cancer, Precancerous Condition
    Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
    University of Wisconsin Chemoprevention Consortium
    Madison, Wisconsin 53706-1969
    Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer
    A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
    Site Reference ID/Investigator# 56811
    Madison, Wisconsin 53705-2275
    Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
    Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Recurrent Neuroblastoma
    Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients
    University of Wisconsin Univ Wisc
    Madison, Wisconsin 53792
    Unspecified Adult Solid Tumor, Protocol Specific, Solid Tumor
    Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
    University of Wisconsin Clinical Science Center
    Madison, Wisconsin 53792
    Castration-resistant Prostate Cancer,, Metastatic Breast Cancer, Uterine Leiomyoma
    Reduced Intensity Conditioning Versus Myeloablative Conditioning for Acute Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
    University of Wisconsin Hospital & Clinics
    Madison, Wisconsin 53792
    Leukemia, Myelocytic, Acute
    Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Prostate Cancer
    Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
    University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health
    Madison, Wisconsin 53711
    Smoking Cessation, Smoking, Nicotine Dependence
    Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    University of Wisconsin - Madison
    Madison, Wisconsin 53792
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Urothelial Carcinoma
    Phase I Biomarker Study (BMS-936558)
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Renal Cell Carcinoma
    Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Extensive Stage Small Cell Lung Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor, Recurrent Breast Cancer, Recurrent Melanoma, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Small Cell Lung Cancer, Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792-6164
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
    University of Wisconsin Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Pancreatic Cancer, Adenocarcinoma, Pancreatic Neoplasms
    Randomized Phase II Study of Single Agent OSI-906 Versus Topotecan for Relapsed Small Cell Lung Cancer (SCLC)
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Lung Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    University of Wisconsin Univ Wisc
    Madison, Wisconsin 53792
    Advanced Solid Tumors, Excluding Breast Cancer
    Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Prostate Cancer
    Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction
    University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
    Madison, Wisconsin 53792
    Sexual Dysfunction, Physiological
    Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
    University of Wisconsin School of Medicine and Public Health
    Madison, Wisconsin 53792-5666
    Gynecologic Cancer, Post-operative Pain
    Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    University of Wisconsin School of Medicine and Public Health
    Smoking Cessation
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Wisconsin Paul P Carbone Comprehensive Cancer Center
    Madison, Wisconsin 53792
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Cancer
    PET/CT Imaging of Malignant Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue 124I-NM404
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Glioblastoma, Brain Metastases
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Dean Hematology and Oncology Clinic
    Madison, Wisconsin 53717
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)
    University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc
    Madison, Wisconsin 53792-6164
    Advanced NET of GI Origin, Advanced NET of Lung Origin, Neuroendocrine Tumors
    Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Combined Type Small Cell Lung Cancer, Fusiform Type Small Cell Lung Cancer, Lymphocyte-like Type Small Cell Lung Cancer, Polygonal Type Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
    University of Wisconsin Hospital and Clinics (Carbone Cancer Center)
    Madison, Wisconsin 53792
    Hot Flashes in Men With Prostate Cancer Receiving Androgen Ablation Therapy
    FdCyd and THU for Advanced Solid Tumors
    Comprehensive Cancer Center
    Madison, Wisconsin
    Neoplasms
    PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Glioblastoma Multiforme, Brain Metastases
    Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose Axitinib
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Solid Malignancies, Metastatic Castrate-resistant Prostate Cancer
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    University of Wisconsin Hospital and Clinics

    Trial Locations
    University of Wisconsin Hospital and Clinics
    Saint Nicholas Hospital
    Breast Cancer
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor
    University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 3

    Trial Locations
    University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 3
    Dean Health System Dean Hematology Oncology
    Breast Cancer
    Tivantinib and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin 53792-0001
    Unspecified Adult Solid Tumor, Protocol Specific
    An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
    University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 5
    Madison, Wisconsin 53792-6164
    Advanced Non Small Cell Lung Cancer (NSCLC)
    A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
    University of Wisconsin Univ Wisc
    Madison, Wisconsin 53792
    Prostatic Neoplasms
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    Saint Nicholas Hospital
    Madison, Wisconsin 53715
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
    University of Wisconsin Hopsital and Clinics
    Madison, Wisconsin 53792
    Infusion Reactions
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Dean Hematology and Oncology Clinic
    Madison, Wisconsin 53717
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Study of 124I-NM404 in Advanced Solid Malignancies
    University of Wisconsin Carbone Cancer Center
    Madison, Wisconsin 53792-5669
    Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    University of Wisconsin-Madison
    Madison, Wisconsin 53792
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer